525 related articles for article (PubMed ID: 30904913)
41. Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus.
Morgenstern DE; Gifford MA; Li LL; Doerschuk CM; Dinauer MC
J Exp Med; 1997 Jan; 185(2):207-18. PubMed ID: 9016870
[TBL] [Abstract][Full Text] [Related]
42. Incidence, severity, and prevention of infections in chronic granulomatous disease.
Mouy R; Fischer A; Vilmer E; Seger R; Griscelli C
J Pediatr; 1989 Apr; 114(4 Pt 1):555-60. PubMed ID: 2784499
[TBL] [Abstract][Full Text] [Related]
43. Impaired p47phox phosphorylation in neutrophils from patients with p67phox-deficient chronic granulomatous disease.
Belambri SA; Marzaioli V; Hurtado-Nedelec M; Pintard C; Liang S; Liu Y; Boussetta T; Gougerot-Pocidalo MA; Ye RD; Dang PM; El-Benna J
Blood; 2022 Apr; 139(16):2512-2522. PubMed ID: 35108370
[TBL] [Abstract][Full Text] [Related]
44. Chronic granulomatous disease in adults.
Liese JG; Jendrossek V; Jansson A; Petropoulou T; Kloos S; Gahr M; Belohradsky BH
Lancet; 1996 Jan; 347(8996):220-3. PubMed ID: 8551880
[TBL] [Abstract][Full Text] [Related]
45. Chronic granulomatous disease: Clinical, molecular, and therapeutic aspects.
Chiriaco M; Salfa I; Di Matteo G; Rossi P; Finocchi A
Pediatr Allergy Immunol; 2016 May; 27(3):242-53. PubMed ID: 26680691
[TBL] [Abstract][Full Text] [Related]
46. The three CYBA variants (rs4673, rs1049254 and rs1049255) are benign: new evidence from a patient with CGD.
Sun J; Wen M; Wang Y; Liu D; Ying W; Wang X
BMC Med Genet; 2017 Nov; 18(1):127. PubMed ID: 29132304
[TBL] [Abstract][Full Text] [Related]
47. Concomitant gene mutations of MBL and CYBB in chronic granulomatous disease: implications for host defense.
Watkins C; Saleh H; Song E; Jaishankar GB; Chi DS; Misran N; Peiris E; Altrich ML; Barklow T; Krishnaswamy G
Inflamm Allergy Drug Targets; 2012 Jun; 11(3):222-6. PubMed ID: 22280238
[TBL] [Abstract][Full Text] [Related]
48. Chronic Granulomatous Disease.
Rawat A; Bhattad S; Singh S
Indian J Pediatr; 2016 Apr; 83(4):345-53. PubMed ID: 26865172
[TBL] [Abstract][Full Text] [Related]
49. X-linked chronic granulomatous disease: first report of mutations in patients of Argentina.
Barese C; Copelli S; Zandomeni R; Oleastro M; Zelazko M; Rivas EM
J Pediatr Hematol Oncol; 2004 Oct; 26(10):656-60. PubMed ID: 15454837
[TBL] [Abstract][Full Text] [Related]
50. Genetics and immunopathology of chronic granulomatous disease.
Stasia MJ; Li XJ
Semin Immunopathol; 2008 Jul; 30(3):209-35. PubMed ID: 18509647
[TBL] [Abstract][Full Text] [Related]
51. Chronic granulomatous disease: a 25-year patient registry based on a multistep diagnostic procedure, from the referral center for primary immunodeficiencies in Greece.
Raptaki M; Varela I; Spanou K; Tzanoudaki M; Tantou S; Liatsis M; Constantinidou N; Bakoula C; Roos D; Kanariou M
J Clin Immunol; 2013 Nov; 33(8):1302-9. PubMed ID: 24081483
[TBL] [Abstract][Full Text] [Related]
52. Inflammatory manifestations in a single-center cohort of patients with chronic granulomatous disease.
Magnani A; Brosselin P; Beauté J; de Vergnes N; Mouy R; Debré M; Suarez F; Hermine O; Lortholary O; Blanche S; Fischer A; Mahlaoui N
J Allergy Clin Immunol; 2014 Sep; 134(3):655-662.e8. PubMed ID: 24985400
[TBL] [Abstract][Full Text] [Related]
53. Regulatory T cell features in chronic granulomatous disease.
van de Geer A; Cuadrado E; Slot MC; van Bruggen R; Amsen D; Kuijpers TW
Clin Exp Immunol; 2019 Aug; 197(2):222-229. PubMed ID: 30924925
[TBL] [Abstract][Full Text] [Related]
54. Approach to Molecular Diagnosis of Chronic Granulomatous Disease (CGD): an Experience from a Large Cohort of 90 Indian Patients.
Kulkarni M; Hule G; de Boer M; van Leeuwen K; Kambli P; Aluri J; Gupta M; Dalvi A; Mhatre S; Taur P; Desai M; Madkaikar M
J Clin Immunol; 2018 Nov; 38(8):898-916. PubMed ID: 30470980
[TBL] [Abstract][Full Text] [Related]
55. Clinical, functional and genetic analysis of twenty-four patients with chronic granulomatous disease - identification of eight novel mutations in CYBB and NCF2 genes.
Martel C; Mollin M; Beaumel S; Brion JP; Coutton C; Satre V; Vieville G; Callanan M; Lefebvre C; Salmon A; Pagnier A; Plantaz D; Bost-Bru C; Eitenschenck L; Durieu I; Floret D; Galambrun C; Chambost H; Michel G; Stephan JL; Hermine O; Blanche S; Blot N; Rubié H; Pouessel G; Drillon-Haus S; Conrad B; Posfay-Barbe KM; Havlicekova Z; Voskresenky-Baricic T; Jadranka K; Arriazu MC; Garcia LA; Sfaihi L; Bordigoni P; Stasia MJ
J Clin Immunol; 2012 Oct; 32(5):942-58. PubMed ID: 22562447
[TBL] [Abstract][Full Text] [Related]
56. Inheritance pattern and clinical aspects of 93 Iranian patients with chronic granulomatous disease.
Fattahi F; Badalzadeh M; Sedighipour L; Movahedi M; Fazlollahi MR; Mansouri SD; Khotaei GT; Bemanian MH; Behmanesh F; Hamidieh AA; Bazargan N; Mamishi S; Zandieh F; Chavoshzadeh Z; Mohammadzadeh I; Mahdaviani SA; Tabatabaei SA; Kalantari N; Tajik S; Maddah M; Pourpak Z; Moin M
J Clin Immunol; 2011 Oct; 31(5):792-801. PubMed ID: 21789723
[TBL] [Abstract][Full Text] [Related]
57. [Molecular aspects of chronic granulomatous disease. "the NADPH oxidase complex"].
Morel F
Bull Acad Natl Med; 2007 Feb; 191(2):377-90; discussion 390-2. PubMed ID: 17969555
[TBL] [Abstract][Full Text] [Related]
58. Mycobacterial disease in patients with chronic granulomatous disease: A retrospective analysis of 71 cases.
Conti F; Lugo-Reyes SO; Blancas Galicia L; He J; Aksu G; Borges de Oliveira E; Deswarte C; Hubeau M; Karaca N; de Suremain M; Guérin A; Baba LA; Prando C; Guerrero GG; Emiroglu M; Öz FN; Yamazaki Nakashimada MA; Gonzalez Serrano E; Espinosa S; Barlan I; Pérez N; Regairaz L; Guidos Morales HE; Bezrodnik L; Di Giovanni D; Dbaibo G; Ailal F; Galicchio M; Oleastro M; Chemli J; Danielian S; Perez L; Ortega MC; Soto Lavin S; Hertecant J; Anal O; Kechout N; Al-Idrissi E; ElGhazali G; Bondarenko A; Chernyshova L; Ciznar P; Herbigneaux RM; Diabate A; Ndaga S; Konte B; Czarna A; Migaud M; Pedraza-Sánchez S; Zaidi MB; Vogt G; Blanche S; Benmustapha I; Mansouri D; Abel L; Boisson-Dupuis S; Mahlaoui N; Bousfiha AA; Picard C; Barbouche R; Al-Muhsen S; Espinosa-Rosales FJ; Kütükçüler N; Condino-Neto A; Casanova JL; Bustamante J
J Allergy Clin Immunol; 2016 Jul; 138(1):241-248.e3. PubMed ID: 26936803
[TBL] [Abstract][Full Text] [Related]
59. CRISPR-gene-engineered CYBB knock-out PLB-985 cells, a useful model to study functional impact of X-linked chronic granulomatous disease mutations: application to the G412E X91+-CGD mutation.
Beaumel S; Verbrugge L; Fieschi F; Stasia MJ
Clin Exp Immunol; 2023 Apr; 212(2):156-165. PubMed ID: 36827093
[TBL] [Abstract][Full Text] [Related]
60. Chronic granulomatous disease with partial deficiency of cytochrome b558 and incomplete respiratory burst: variants of the X-linked, cytochrome b558-negative form of the disease.
Roos D; de Boer M; Borregard N; Bjerrum OW; Valerius NH; Seger RA; Mühlebach T; Belohradsky BH; Weening RS
J Leukoc Biol; 1992 Feb; 51(2):164-71. PubMed ID: 1431553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
